Caeli Vascular is a medical technology company headquartered in Chesterfield, Missouri. They have developed a venous thrombectomy device that combines mechanical, chemical, and suction thrombectomy techniques. This device allows for efficient fragmentation and evacuation of blood clots in large veins while minimizing the risk of complications such as vein wall trauma and blood loss. By isolating thrombolytic drugs and thrombus microemboli within a defined treatment zone, doctors and clinicians can improve clinical outcomes for thrombectomy procedures. Caeli Vascular was founded in 2019.